Can metronidazole (Flagyl) be taken concurrently with nitrofurantoin (Macrobid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concurrent Use of Flagyl (Metronidazole) and Macrobid (Nitrofurantoin)

Yes, metronidazole (Flagyl) and nitrofurantoin (Macrobid) can be safely taken together—there are no known drug interactions or contraindications to concurrent use, and they are frequently combined in clinical practice for infections requiring coverage of both anaerobic bacteria and urinary pathogens.

Rationale for Concurrent Use

These two antibiotics have completely different mechanisms of action and spectrums of activity, making them complementary rather than conflicting:

  • Metronidazole targets anaerobic bacteria and certain protozoa through DNA damage after intracellular activation by microbial nitroreductases 1, 2
  • Nitrofurantoin is specifically concentrated in urine and targets common urinary pathogens including E. coli, Staphylococcus saprophyticus, and Enterococcus species 3, 4

Clinical Scenarios Supporting Combined Use

Intra-abdominal Infections with Concurrent UTI

Guidelines explicitly recommend metronidazole in combination regimens for intra-abdominal infections. If a patient with an intra-abdominal infection also develops a urinary tract infection, adding nitrofurantoin is appropriate:

  • For mild-to-moderate intra-abdominal infections, metronidazole is combined with cephalosporins, fluoroquinolones, or aminoglycosides 3
  • Nitrofurantoin would address a concurrent uncomplicated cystitis without interfering with anaerobic coverage 3

Separate Infection Sites

The most common scenario is treating two distinct infections simultaneously:

  • Metronidazole for anaerobic infections (bacterial vaginosis, Trichomonas vaginalis, C. difficile, anaerobic abdominal infections) 3, 1, 5
  • Nitrofurantoin for uncomplicated urinary tract infection 3, 4

Safety Profile

Both medications are well-tolerated when used appropriately:

  • Nitrofurantoin adverse events occur in approximately 15-28% of patients, with drug-related events in only 5.6-8.8%, primarily nausea and headache 3, 6
  • Metronidazole has an acceptable adverse effect profile with good tissue penetration 1
  • No pharmacokinetic interactions exist between these agents 2

Critical Contraindications to Monitor

For Nitrofurantoin:

  • Renal impairment of any degree—nitrofurantoin is absolutely contraindicated as it requires adequate renal function for urinary concentration 4
  • Last trimester of pregnancy (third trimester) due to risk of hemolytic anemia in the newborn 4
  • Not appropriate for pyelonephritis or systemic infections—only achieves therapeutic levels in urine 3, 7

For Metronidazole:

  • Avoid alcohol during and for 48 hours after treatment (disulfiram-like reaction) 1
  • Use caution in pregnancy, though multiple studies show no consistent teratogenic effects 3

Practical Prescribing Approach

When prescribing both medications concurrently:

  • Verify renal function before starting nitrofurantoin—check creatinine clearance 7, 4
  • Confirm the urinary infection is uncomplicated cystitis, not pyelonephritis or complicated UTI 3
  • Standard dosing: Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5-7 days 3
  • Standard dosing: Metronidazole 500 mg twice daily for 7 days (for Trichomonas) or as indicated for other anaerobic infections 3, 1
  • Counsel patients to avoid alcohol with metronidazole 1
  • Monitor for nausea, which can occur with both agents 3, 1

Common pitfall to avoid: Do not use nitrofurantoin for complicated UTIs, pyelonephritis, or any systemic infection—it only achieves therapeutic concentrations in urine 3, 7, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Research

Flagyl (metronidazole hydrochloride).

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates, 1993

Guideline

Antibiotic Treatment for Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.